Fideuram Intesa Sanpaolo Private Banking S.P.A. Sells 10,347 Shares of Corteva, Inc. $CTVA

Fideuram Intesa Sanpaolo Private Banking S.P.A. reduced its stake in shares of Corteva, Inc. (NYSE:CTVA) by 7.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 132,291 shares of the company’s stock after selling 10,347 shares during the quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A.’s holdings in Corteva were worth $11,074,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of CTVA. JPL Wealth Management LLC purchased a new stake in shares of Corteva in the 3rd quarter worth $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva in the fourth quarter valued at about $27,000. Bank of Jackson Hole Trust bought a new position in Corteva in the fourth quarter worth about $28,000. Cornerstone Financial Management LLC bought a new position in Corteva in the fourth quarter worth about $29,000. Finally, Basepoint Wealth LLC purchased a new stake in Corteva during the fourth quarter valued at approximately $30,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

NYSE:CTVA opened at $85.63 on Friday. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.95. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a 50 day moving average price of $79.67 and a 200 day moving average price of $76.80. The stock has a market cap of $57.27 billion, a PE ratio of 50.37, a P/E/G ratio of 2.56 and a beta of 0.56.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. Corteva’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s dividend payout ratio is currently 42.35%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of research analyst reports. The Goldman Sachs Group increased their price target on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. CICC Research boosted their target price on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Wells Fargo & Company upped their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 21st. Morgan Stanley raised their target price on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Finally, Rothschild & Co Redburn upped their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.